ATOS
ATOS
NASDAQ · Biotechnology

Atossa Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.87
-0.28 (-5.44%)
As of May 16, 2:21 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +72.9% upside
Low Target $5.85
Average Target $8.42
High Target $9.99
Current Price $4.87
Current
$4.87
Target
$8.42
$5.85 $8.42 avg $9.99
Scenario Analysis
Bear Case
$5.85
20.1%
Low target
Base Case
$8.42
+72.9%
Avg target
Bull Case
$9.99
+105.1%
High target
Risk/Reward
5.2x
Highly favorable
Price in Context
52-Week High
$19.35
-74.8% from high
52-Week Low
$3.76
+29.5% from low
Target vs 52W High
$8.42
-56.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%